Clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries: A systematic review and network meta-analysis

BackgroundPercutaneous coronary intervention (PCI) has a well-established role in revascularization for coronary artery disease. We performed network meta-analysis to provide evidence on optimal intervention strategies for de novo lesions in small coronary arteries.Materials and methodsEnrolled stud...

Full description

Bibliographic Details
Main Authors: Wen-Rui Ma, Karthik H. Chandrasekharan, Chang-Sheng Nai, Yong-Xiang Zhu, Javaid Iqbal, Shang Chang, You-Wei Cheng, Xin-Yu Wang, Christos V. Bourantas, Yao-Jun Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1017833/full
_version_ 1811224950339534848
author Wen-Rui Ma
Karthik H. Chandrasekharan
Chang-Sheng Nai
Yong-Xiang Zhu
Javaid Iqbal
Shang Chang
You-Wei Cheng
Xin-Yu Wang
Christos V. Bourantas
Yao-Jun Zhang
author_facet Wen-Rui Ma
Karthik H. Chandrasekharan
Chang-Sheng Nai
Yong-Xiang Zhu
Javaid Iqbal
Shang Chang
You-Wei Cheng
Xin-Yu Wang
Christos V. Bourantas
Yao-Jun Zhang
author_sort Wen-Rui Ma
collection DOAJ
description BackgroundPercutaneous coronary intervention (PCI) has a well-established role in revascularization for coronary artery disease. We performed network meta-analysis to provide evidence on optimal intervention strategies for de novo lesions in small coronary arteries.Materials and methodsEnrolled studies were randomized clinical trials that compared different intervention strategies [balloon angioplasty (BA), biolimus-coated balloon (BCB), bare-metal stent (BMS), new-generation drug-eluting stent (New-DES), older generation sirolimus-eluting stent (Old-SES), paclitaxel-coated balloon (PCB), and paclitaxel-eluting stent (PES)] for de novo lesions in small coronary arteries. The primary outcome was major adverse cardiac events (MACE).ResultsA total of 23 randomized clinical trials comparing seven intervention devices were analyzed. In terms of the primary outcome, New-DES was the intervention device with the best efficacy [surface under the cumulative ranking curve (SUCRA), 89.1%; mean rank, 1.7], and the Old-SES [risk ratio (RR), 1.09; 95% confidence interval (CI), 0.45–2.64] and PCB (RR, 1.40; 95% CI, 0.72–2.74) secondary to New-DES, but there was no statistically significant difference between these three intervention devices. All DES and PCB were superior to BMS and BA for MACE in both primary and sensitivity analysis. For secondary outcomes, there was no association between all-cause mortality and myocardial infarction (MI) with any intervention strategy, and additionally, the findings of target lesion revascularization (TLR) were similar to the primary outcomes.ConclusionPaclitaxel-coated balloon yielded similar outcomes to New-DES for de novo lesions in small coronary arteries. Therefore, this network meta-analysis may provide potential support for PCB as a feasible, effective, and safe alternative intervention strategy for the revascularization of small coronary arteries.Systematic review registration[https://www.crd.york.ac.uk/PROSPERO/#recordDetails], identifier [CRD42022338433].
first_indexed 2024-04-12T08:57:25Z
format Article
id doaj.art-b5a5687b3b324fda84f491a20bb39e3e
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-12T08:57:25Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-b5a5687b3b324fda84f491a20bb39e3e2022-12-22T03:39:20ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-11-01910.3389/fcvm.2022.10178331017833Clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries: A systematic review and network meta-analysisWen-Rui Ma0Karthik H. Chandrasekharan1Chang-Sheng Nai2Yong-Xiang Zhu3Javaid Iqbal4Shang Chang5You-Wei Cheng6Xin-Yu Wang7Christos V. Bourantas8Yao-Jun Zhang9Department of Cardiology, Xuzhou Third People’s Hospital, Xuzhou Medical University, Xuzhou, ChinaDepartment of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United KingdomDepartment of Cardiology, Xuzhou Third People’s Hospital, Xuzhou Medical University, Xuzhou, ChinaDepartment of Cardiology, Xuzhou Third People’s Hospital, Xuzhou Medical University, Xuzhou, ChinaDepartment of Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United KingdomDepartment of Cardiology, Xuzhou Third People’s Hospital, Xuzhou Medical University, Xuzhou, ChinaDepartment of Cardiology, Xuzhou Third People’s Hospital, Xuzhou Medical University, Xuzhou, ChinaDepartment of Cardiology, Xuzhou Third People’s Hospital, Xuzhou Medical University, Xuzhou, ChinaDepartment of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United KingdomDepartment of Cardiology, Xuzhou Third People’s Hospital, Xuzhou Medical University, Xuzhou, ChinaBackgroundPercutaneous coronary intervention (PCI) has a well-established role in revascularization for coronary artery disease. We performed network meta-analysis to provide evidence on optimal intervention strategies for de novo lesions in small coronary arteries.Materials and methodsEnrolled studies were randomized clinical trials that compared different intervention strategies [balloon angioplasty (BA), biolimus-coated balloon (BCB), bare-metal stent (BMS), new-generation drug-eluting stent (New-DES), older generation sirolimus-eluting stent (Old-SES), paclitaxel-coated balloon (PCB), and paclitaxel-eluting stent (PES)] for de novo lesions in small coronary arteries. The primary outcome was major adverse cardiac events (MACE).ResultsA total of 23 randomized clinical trials comparing seven intervention devices were analyzed. In terms of the primary outcome, New-DES was the intervention device with the best efficacy [surface under the cumulative ranking curve (SUCRA), 89.1%; mean rank, 1.7], and the Old-SES [risk ratio (RR), 1.09; 95% confidence interval (CI), 0.45–2.64] and PCB (RR, 1.40; 95% CI, 0.72–2.74) secondary to New-DES, but there was no statistically significant difference between these three intervention devices. All DES and PCB were superior to BMS and BA for MACE in both primary and sensitivity analysis. For secondary outcomes, there was no association between all-cause mortality and myocardial infarction (MI) with any intervention strategy, and additionally, the findings of target lesion revascularization (TLR) were similar to the primary outcomes.ConclusionPaclitaxel-coated balloon yielded similar outcomes to New-DES for de novo lesions in small coronary arteries. Therefore, this network meta-analysis may provide potential support for PCB as a feasible, effective, and safe alternative intervention strategy for the revascularization of small coronary arteries.Systematic review registration[https://www.crd.york.ac.uk/PROSPERO/#recordDetails], identifier [CRD42022338433].https://www.frontiersin.org/articles/10.3389/fcvm.2022.1017833/fullclinical outcomede novo lesionsdrug-coated balloonnew-generation drug-eluting stentsmall coronary arteries
spellingShingle Wen-Rui Ma
Karthik H. Chandrasekharan
Chang-Sheng Nai
Yong-Xiang Zhu
Javaid Iqbal
Shang Chang
You-Wei Cheng
Xin-Yu Wang
Christos V. Bourantas
Yao-Jun Zhang
Clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries: A systematic review and network meta-analysis
Frontiers in Cardiovascular Medicine
clinical outcome
de novo lesions
drug-coated balloon
new-generation drug-eluting stent
small coronary arteries
title Clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries: A systematic review and network meta-analysis
title_full Clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries: A systematic review and network meta-analysis
title_fullStr Clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries: A systematic review and network meta-analysis
title_full_unstemmed Clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries: A systematic review and network meta-analysis
title_short Clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries: A systematic review and network meta-analysis
title_sort clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries a systematic review and network meta analysis
topic clinical outcome
de novo lesions
drug-coated balloon
new-generation drug-eluting stent
small coronary arteries
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.1017833/full
work_keys_str_mv AT wenruima clinicaloutcomesofpercutaneouscoronaryinterventionfordenovolesionsinsmallcoronaryarteriesasystematicreviewandnetworkmetaanalysis
AT karthikhchandrasekharan clinicaloutcomesofpercutaneouscoronaryinterventionfordenovolesionsinsmallcoronaryarteriesasystematicreviewandnetworkmetaanalysis
AT changshengnai clinicaloutcomesofpercutaneouscoronaryinterventionfordenovolesionsinsmallcoronaryarteriesasystematicreviewandnetworkmetaanalysis
AT yongxiangzhu clinicaloutcomesofpercutaneouscoronaryinterventionfordenovolesionsinsmallcoronaryarteriesasystematicreviewandnetworkmetaanalysis
AT javaidiqbal clinicaloutcomesofpercutaneouscoronaryinterventionfordenovolesionsinsmallcoronaryarteriesasystematicreviewandnetworkmetaanalysis
AT shangchang clinicaloutcomesofpercutaneouscoronaryinterventionfordenovolesionsinsmallcoronaryarteriesasystematicreviewandnetworkmetaanalysis
AT youweicheng clinicaloutcomesofpercutaneouscoronaryinterventionfordenovolesionsinsmallcoronaryarteriesasystematicreviewandnetworkmetaanalysis
AT xinyuwang clinicaloutcomesofpercutaneouscoronaryinterventionfordenovolesionsinsmallcoronaryarteriesasystematicreviewandnetworkmetaanalysis
AT christosvbourantas clinicaloutcomesofpercutaneouscoronaryinterventionfordenovolesionsinsmallcoronaryarteriesasystematicreviewandnetworkmetaanalysis
AT yaojunzhang clinicaloutcomesofpercutaneouscoronaryinterventionfordenovolesionsinsmallcoronaryarteriesasystematicreviewandnetworkmetaanalysis